Clinical and Genetic Characteristics of Long QT Syndrome Argelia Medeiros-Domingo,A,C Pedro Iturralde-Torres,B and Michael J

Total Page:16

File Type:pdf, Size:1020Kb

Clinical and Genetic Characteristics of Long QT Syndrome Argelia Medeiros-Domingo,A,C Pedro Iturralde-Torres,B and Michael J Document downloaded from http://www.revespcardiol.org, day 09/04/2016. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. REVIEW ARTICLE Clinical and Genetic Characteristics of Long QT Syndrome Argelia Medeiros-Domingo,a,c Pedro Iturralde-Torres,b and Michael J. Ackermanc aUnidad de Biología Molecular y Medicina Genómica, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de Mexico, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico bInstituto Nacional de Cardiología Ignacio Chávez, Mexico cDepartment of Medicine/Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA Long QT syndrome (LQTS) is an arrhythmogenic ion Clínica y genética en el síndrome de QT largo channel disorder characterized by severely abnormal ventricular repolarization, which results in QT internal El síndrome de QT largo (SQTL) es una canalopatía prolongation. The condition is associated with sudden arritmogénica caracterizada por una grave alteración en cardiac death due to malignant ventricular arrhythmias in la repolarización ventricular, traducida electrocardiográfi- form of torsade de pointes. Eleven years after the camente por una prolongación del intervalo QT. Predis- identification of the principle cardiac channels involved in pone a muerte súbita por arritmias ventriculares malignas the condition, hundreds of mutations in, to date, 10 genes del tipo de torsade de pointes. A 11 años de la identifica- have been associated with the syndrome. Genetic ción de los principales canales afectados en esta enfer- investigations carried out up until the present have shown medad, se han descrito cientos de mutaciones distribui- that, although the severe form of the disease is sporadic, das en hasta ahora 10 genes relacionados con el there are a number of common polymorphisms in genes síndrome. El escrutinio genético realizado desde enton- associated with the condition that may confer susceptibility ces ha mostrado que, si bien la forma grave de la enfer- to the development of torsade de pointes in some medad es esporádica, hay polimorfismos comunes en los individuals, particularly when specific drugs are being genes relacionados con la enfermedad que pueden gene- administered. Moreover, some polymorphisms have been rar susceptibilidad individual al desarrollo de torsade de shown to have regulatory properties that either enhance pointes, en particular con el uso de determinados fárma- or counteract a particular mutation’s impact. Understanding cos; más aún, se han identificado polimorfismos con cua- of the molecular processes underlying the syndrome has lidades reguladoras que pueden exacerbar o silenciar la enabled treatment to be optimized and has led to better gravedad de una mutación. El entendimiento de los pro- survival among sufferers, thereby demonstrating a key cesos moleculares de la enfermedad ha permitido opti- correspondence between genotype, phenotype, and mizar el tratamiento y mejorar la supervivencia de los therapy. Despite these developments, a quarter of patients afectados, generando así una importante correlación ge- do not have mutations in the genes identified to date. notipo-fenotipo-tratamiento. A pesar de los avances, una Consequently, LQTS continues to be an area of active cuarta parte de los casos no tiene mutaciones en los ge- research. This article contains a summary of the main nes descritos hasta el momento, por lo que el SQTL con- clinical and genetic developments concerning the syndrome tinúa siendo motivo de investigación. El presente artículo that have taken place during the last decade. representa el análisis de los principales conceptos clíni- cos y genéticos desarrollados en los últimos años sobre Key words: Long QT syndrome. Arrhythmias. Sudden esta singular enfermedad. death. Cardiac arrest. Syncope. Gene mutation. Torsade de pointes. Palabras clave: Síndrome de QT largo. Arritmias. Muerte súbita. Parada cardiaca. Síncope. Mutación genética. Torsade de pointes. SEE EDITORIAL ON PAGES 675-82 INTRODUCTION Dr. Medeiros receives economic support from CONACyT Long QT syndrome (LQTS) is characterized by severely and FUNSALUD. altered ventricular repolarization, resulting in prolongation Correspondence: of the QT interval on electrocardiogram (ECG). The Dra. A. Medeiros-Domingo. Unidad de Biología Molecular. Instituto Nacional de Ciencias Médicas condition predisposes patients to malignant ventricular y Nutrición Salvador Zubirán. arrhythmia (torsade de pointes) and sudden death. The Vasco de Quiroga, 15. Tlalpan 14000. Mexico DF. Mexico. clinical and electrocardiographic description of long QT E-mail: [email protected] syndrome was reported in 1957 by Anton Jervell and Rev Esp Cardiol. 2007;60(7):739-52 739 Document downloaded from http://www.revespcardiol.org, day 09/04/2016. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Medeiros-Domingo A et al. Clinical and Genetic of Long QT Syndrome patients who have the mutation and manifest the ABBREVIATIONS phenotype, ranges from 25% to 90%.9 Less frequently, AV: atrioventricular there may be variations in the expressivity of the disease, AID: automatic implantable defibrillator with several phenotypes resulting from the same ECG: electrocardiogram mutation. Molecular genetic studies developed over the QTc: heart rate-corrected QT last 11 years have yielded important genotype-phenotype ATS: Andersen-Tawil syndrome correlations, which have helped to guide the treatment LQTS: long QT syndrome approach. In addition, interesting observations have been made on individual susceptibility to developing arrhythmia in studies investigating the frequent nonsynonymous polymorphisms in this population, an aspect that has aroused considerable interest, particularly Fred Lange Nielsen,1 who published their studies on a in the area of pharmacogenomics. family of nonconsanguineous parents with 6 children. Four of the children had congenital deafness and syncopal CLASSIFICATION OF LONG QT SYNDROME episodes, and 3 presented sudden death. ECG study of these patients showed an unusually long QT interval. General Concepts Both parents were asymptomatic, had a normal ECG, and presented no hearing problems. In 1964, Romano The LQTS classification used in the past was based on and Ward independently reported a cardiac syndrome the homozygous or heterozygous presentation of the characterized by recurrent syncope, a family history of disease, which gives rise to Jervell-Lange-Nielsen sudden death, and prolongation of the QT interval without syndrome (with deafness) and Romano-Ward syndrome neuronal deafness.2 Later genetic studies showed that the (without deafness), respectively. The present classification syndrome described by Jervell and Lange Nielsen, which emphasizes the genetic findings, as is illustrated in Table 1. is accompanied by congenital neuronal deafness, The 3 main genes associated with the disease were corresponds to homozygous mutations, with a severe described in 1995-1996. These genes, which code for phenotype and high risk of sudden death. The condition pore-forming units of the potassium channels IKs and IKr, known as Romano-Ward syndrome generally corresponds and the sodium channel Nav1.5, account for nearly 65% to heterozygous mutations, patients do not display hearing of the cases. Although in subsequent years seven additional alterations, and the severity of the disease varies genes have been included in the list, they account for considerably. Almost half a century later, in 1995,3,4 the only 5% of the cases. principal genes associated with LQTS were described Ion channels are transmembrane proteins that transport and the disease was recognized as a cardiac ion channel ions through the cell membrane. The channels implicated disorder. It was the first cardiac channelopathy to be in LQTS are selective or specialized in transporting a described and is perhaps the most extensively investigated single ion and are voltage-dependent, ie, their activation arrhythmogenic ion channel disorder to date. The clinical occurs at a specific intracellular voltage, which varies picture varies greatly: the patient can be asymptomatic, according to the channel subtype. The electrical and or show recurrent syncope, seizures, or sudden death as contractile phenomena that occur in the cardiomyocyte the first manifestation of the disease. Initially, LQTS was are controlled by these structures. Ion channels form considered a rare syndrome and, in effect, the severe macromolecular complexes consisting of a main unit that presentation of the disease is sporadic. Nonetheless, the forms the channel pore and auxiliary proteins that regulate incidence of related mutations is estimated at 1/3000- it (Figure 1). The channel dysfunction seen in LQTS can 5000 cases,5 32% of asymptomatic carriers can have a occur at these two sites: the main protein or the regulating heart rate-corrected QT interval (QTc) within normal proteins (Table 1). Involvement of the pore-forming unit, limits, the disease is transmitted to 50% of their known as alpha, generates the three most common subtypes descendants, they are more susceptible to develop of LQTS: LQTS1 (affecting the IKs potassium channel), arrhythmia when compared to the general population, LQTS2 (affecting the IKr potassium channel), and LQTS3 and up to 20% can become symptomatic.6 (affecting the sodium channel). Because these are the Long QT syndrome displays great
Recommended publications
  • ARIC Cohort Stroke Form Instructions STR, VERSION F Qxq, 01/23/2020
    STRF Instructions (QxQs) This table summarizes changes to the STRF QxQ as of 01/23/2020 Question in STRF QxQ Description of Changes in STRF QXQ Section G., pg. 2 Record “2 days” when seeing “few days” Item 17., pg. 5 Remove ICD-10 codes (I65.x, I66.x, or I67.x) Item 21, pg. 6 Clarifications made on how to record this question if there are multiple TIAs Item 29.b., pg. 9 Clarifications made on how to record intracardia thrombus Item 29.c., pg. 9 Clarifications made on how to record atrial fibrillation or flutter Item 29.d., pg. 9 Clarifications made on how to record valvular heart disease Items 29.j.& 29.k., pg. 11 Remove “amyloid angiopathy or amyloidosis” from the “central nervous system” list Item 30.e. Clarifications made on how to record therapy with heparin or warfarin Item 44, pg. 15 Added “hemisensory” to the synonym list Items 48.d.1.& 48.e.1., pg. 18 Clarifications made on how to record stenosis Items 49 & 50, pg. 19 Clarifications made on how to record CT Scan Items 49.d.& 50.d., pg. 19 Clarifications made on how to record CT diagnosis Item 52.d., pg. 21 Clarifications made on how to record MRI diagnosis Items 53.c.1. and 53.d.1., pg. 21 Clarifications made on how to record the exact stenosis for right and left internal carotid artery of the neck Appendix B, pg. 27 and pg. 28 Clarifications made to the instructions regarding unrelated pathology or findings Appendix C, pg. 30 Updates made to hospital codes Appendix G, pg.
    [Show full text]
  • PAROXYSMAL VENTRICULAR TACHYCARDIA OCCURRING in a NORMAL HEART by DAVID ROMNEY, M.B., B.Ch.(Dub.) Ex-Senior House Officer in Medicine, St
    Postgrad Med J: first published as 10.1136/pgmj.31.354.191 on 1 April 1955. Downloaded from I9I -J PAROXYSMAL VENTRICULAR TACHYCARDIA OCCURRING IN A NORMAL HEART By DAVID ROMNEY, M.B., B.Ch.(Dub.) Ex-Senior House Officer in Medicine, St. James's Hospital, Balham It is widely taught-and rightly so-that by sinus pressure will, of course, not affect the paroxysmal ventricular tachycardia is one of the rate in ventricular tachycardia. rarer arrhythmias, and is associated with grave In I953 Froment, Gallavardin and Cahen myocardial damage, with special reference to myo- offered a classification of various forms of cardial infarction. It is the least common, and paroxysmal ventricular tachycardia, and included most serious of the paroxysmal tachycardias, some case report. They described the following which contain four varieties of arrhythmia: supra- groups:- ventricular (auricular and nodal) 60 per cent.; (i) Terminal prefibrillatory ventricular tachy- auricular fibrillation, 30 per cent.; auricular flutter, cardia. 6 per cent.; and ventricular tachycardia, 4 per (ii) Curable and mild monomorphic extra- cent. systoles, with paroxysms of tachycardia. Figures from various sources (Campbell, 1947) (iii) Paroxysmal ventricular tachycardia due toby copyright. would indicate that in the latter group, four-fifths a lesion of the ventricular septum. of the cases had seriously damaged hearts. In (iv) Persistent and prolonged ventricular tachy- the remaining fifth no cause was found for the cardia developing in sound hearts, usually paroxysms. Paroxysmal ventricular tachycardia is in young subjects. more common in men than in women in the proportion of about 3.2. This arrhythmia was Case Report first identified by Sir Thomas Lewis in I909 and A married woman, aged 48, first became aware Gallavardin (1920, I921, 1922) emphasized the in 1948 of a paroxysm which caused alarm, faint- seriousness of the 'terminal ven- ness and It lasted a short pre-fibrillatory collapse.
    [Show full text]
  • Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 3054 Date: August 29, 2014 Change Request 8803
    Department of Health & CMS Manual System Human Services (DHHS) Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 3054 Date: August 29, 2014 Change Request 8803 SUBJECT: Ventricular Assist Devices for Bridge-to-Transplant and Destination Therapy I. SUMMARY OF CHANGES: This Change Request (CR) is effective for claims with dates of service on and after October 30, 2013; contractors shall pay claims for Ventricular Assist Devices as destination therapy using the criteria in Pub. 100-03, part 1, section 20.9.1, and Pub. 100-04, Chapter 32, sec. 320. EFFECTIVE DATE: October 30, 2013 *Unless otherwise specified, the effective date is the date of service. IMPLEMENTATION DATE: September 30, 2014 Disclaimer for manual changes only: The revision date and transmittal number apply only to red italicized material. Any other material was previously published and remains unchanged. However, if this revision contains a table of contents, you will receive the new/revised information only, and not the entire table of contents. II. CHANGES IN MANUAL INSTRUCTIONS: (N/A if manual is not updated) R=REVISED, N=NEW, D=DELETED-Only One Per Row. R/N/D CHAPTER / SECTION / SUBSECTION / TITLE D 3/90.2.1/Artifiical Hearts and Related Devices R 32/Table of Contents N 32/320/Artificial Hearts and Related Devices N 32/320.1/Coding Requirements for Furnished Before May 1, 2008 N 32/320.2/Coding Requirements for Furnished After May 1, 2008 N 32/320.3/ Ventricular Assist Devices N 32/320.3.1/Postcardiotomy N 32/320.3.2/Bridge-To -Transplantation (BTT) N 32/320.3.3/Destination Therapy (DT) N 32/320.3.4/ Other N 32/320.4/ Replacement Accessories and Supplies for External Ventricular Assist Devices or Any Ventricular Assist Device (VAD) III.
    [Show full text]
  • View Pdf Copy of Original Document
    Phenotype definition for the Vanderbilt Genome-Electronic Records project Identifying genetics determinants of normal QRS duration (QRSd) Patient population: • Patients with DNA whose first electrocardiogram (ECG) is designated as “normal” and lacking an exclusion criteria. • For this study, case and control are drawn from the same population and analyzed via continuous trait analysis. The only difference will be the QRSd. Hypothetical timeline for a single patient: Notes: • The study ECG is the first normal ECG. • The “Mildly abnormal” ECG cannot be abnormal by presence of heart disease. It can have abnormal rate, be recorded in the presence of Na-channel blocking meds, etc. For instance, a HR >100 is OK but not a bundle branch block. • Y duration = from first entry in the electronic medical record (EMR) until one month following normal ECG • Z duration = most recent clinic visit or problem list (if present) to one week following the normal ECG. Labs values, though, must be +/- 48h from the ECG time Criteria to be included in the analysis: Criteria Source/Method “Normal” ECG must be: • QRSd between 65-120ms ECG calculations • ECG designed as “NORMAL” ECG classification • Heart Rate between 50-100 ECG calculations • ECG Impression must not contain Natural Language Processing (NLP) on evidence of heart disease concepts (see ECG impression. Will exclude all but list below) negated terms (e.g., exclude those with possible, probable, or asserted bundle branch blocks). Should also exclude normalization negations like “LBBB no longer present.”
    [Show full text]
  • Polymorphic Catecholergic Ventricular Tachycardia
    Polymorphic catecholergic ventricular tachycardia Author: Doctor Vincent Lucet1 Creation Date: March 2000 Update: August 2002 January 2004 Scientific Editor: Doctor Damien Bonnet 1pédiatrie générale, Château des Côtes, 78350 Les Loges En Josas, France. [email protected] Abstract Keywords Name of the disease and its synonyms Names of excluded diseases Diagnostic criteria/Definition Differential diagnosis Frequence Clinical description Management/treatment Etiology Biological diagnostic method Genetic counseling Unresolved questions and comments References Abstract Identified in 1978, catecholaminergic polymorphic ventricular tachycardia mainly occurs in children over 3 years old with apparently healthy hearts. It is a primary dysrhythmia usually discovered during the work-up conducted after syncope with or without seizure. Syncopes mainly occur during exertion or emotional experiences. The electrocardiogram is normal (particularly the QT interval). During exercise or acceleration of the sinus rhythm, stereotyped and repetitive ventricular extrasystoles appear: first isolated and monomorphic, they become polymorphic and occur in salvos, with bidirectional ventricular tachycardia. Ventricular arrhythmia may be very rapid and interspersed with bursts of supraventricular or junctional tachycardia. During the paroxysms, torsade en pointes and ventricular fibrillation may appear and sometimes revert spontaneously. The same arrhythmia can be induced by stress tests or injecting small doses of isoprenaline. Patients are treated with powerful beta-blockers with delayed action. The spontaneous outcome is poor: half of the untreated patients die before age of 20 years. The disorder, recently assigned to the group of rhythm channelopathies, is familial in 1/3 cases. Somes cases are associated with abnormal transmembrane calcium transport (a mutation of the cardiac ryanodine-receptor gene, RyR2, has been found in several families).
    [Show full text]
  • Paroxysmal Auricular Tachycardia with Block Ralph M
    Henry Ford Hospital Medical Journal Volume 3 | Number 3 Article 10 9-1955 Paroxysmal Auricular Tachycardia With Block Ralph M. Denham Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Denham, Ralph M. (1955) "Paroxysmal Auricular Tachycardia With Block," Henry Ford Hospital Medical Bulletin : Vol. 3 : No. 3 , 154-160. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol3/iss3/10 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact [email protected]. PAROXYSMAL AURICULAR TACHYCARDIA WITH BLOCK RALPH M. DENHAM, M.D.* Paroxysmal auricular tachycardia is a relatively common arrhythmia. The rate is usually between 150 and 220 per minute and the ventricles usuafly respond to each auricular beat. The attacks are usually of abrupt onset and last a few minutes or a few hours. Rarely they may last several days. Vagal stimulation, digitalis and quinidine usually wifl stop the attack. Barker and co-workers^ point out that auricular tachycardia seldom occurs in patients who have had previous attacks of auricular flutter or fibrillation, and that these disturbances, which are caused by circus rhythm are uncommon in patients who have had auricular paroxysmal tachycardia. In 1943 Barker and co-workers^ stated that, "In rare instances of auricular paroxys­ mal tachycardia, the ventricles do not respond to each auricular beat in the usual manner." In their paper they reviewed seventeen previously reported cases and added eighteen additional cases of auricular tachycardia with block.
    [Show full text]
  • The Roles of Electrical Cardiac Systole Sudden Death
    Journal of Cardiology & Current Research The Roles of Electrical Cardiac Systole Sudden Death Abstract Review Article The definition of sudden death had to be explained in many other chapters of Volume 3 Issue 3 - 2015 this book. So I will not go into more details regarding it. The sudden death in the absence of structural heart disease is uncommon, but when it appears, has a very Francisco R Breijo Marquez* significant clinical impact because many of the victims are young. In relatively School of Medicine, Commemorative Hospital, USA recent form it has given special attention to particular conditions expressed in repolarization electrocardiographies on the QT interval, whose relationship with *Corresponding author: Francisco R Breijo Marquez, the functionality of some ion channels in the membrane cell has prompted its School of Medicine, Commemorative Hospital, USA; designation as “channelopathies”. But the QT-interval alteration is not unique. Email: Keywords: Electrical cardiac systole disturbances; Long and Short QT-Syndromes; Received: August 11, 2014 | Published: August 27, 2014 The short PR-interval disturbances; Sudden cardiac death Abbreviations: ECG: Electrocardiography; WPW: Wolff- Parkinson-White; TSH: Thyroid-Stimulating; LBBB: Left Bundle Branch Block Bundles The Electrical Cardiac Systole Disorders in the electrical cardiac systole can be very dangerous for sudden death, as some cardiac entities previously cited in this book. Its role in sudden death is very important. Before anything else, it is essential to know what is considered as “electrical cardiac systole”. For some authors it would be from the beginning of the Q-wave until the end of T-wave. In contrast, for other authors, including us, it would be from the beginning of the P-wave until the end of T-wave, including the P- wave and the PR- interval (Figure 1).
    [Show full text]
  • Abnormal P Waves and Paroxysmal Tachycardia
    Brit. Heart J., 1963, 25, 570. Br Heart J: first published as 10.1136/hrt.25.5.570 on 1 September 1963. Downloaded from ABNORMAL P WAVES AND PAROXYSMAL TACHYCARDIA BY L. G. DAVIES* AND I. P. ROSSt From The National Heart Hospital, London Received January 28, 1963 Specific changes in the P wave of the electrocardiogram have been recognized in mitral stenosis (Lewis and Gilder, 1912), pulmonary heart disease (Winternitz, 1935), left ventricular failure (Wood and Selzer, 1939), and congenital heart disease (Paul, Myers, and Campbell, 1951). These changes are believed to be the result of right or left atrial hypertrophy (Reynolds, 1953; Thomas, and Dejong, 1954). We have noticed P wave abnormalities in some patients with paroxysmal tachycardia, an observation that does not appear to have been reported by other workers. In our patients the abnormal P waves were prolonged, usually to 0@12 second or more, and were frequently notched. These abnormalities were not due to any of the recognized causes for these hearts were clinically normal. As a pilot study 50 electrocardiograms from patients with paroxysmal tachy- cardia and 50 from normal controls were mixed together and studied independently by four obser- vers. The results confirmed our preliminary observations and we decided to study a larger series. copyright. SUBJECTS AND METHODS We examined the records of patients in whom a firm clinical diagnosis of paroxysmal tachycardia had been made. Those patients with organic heart disease were excluded, so were a number with normal hearts where the electrocardiograms were unsatisfactory because of sinus tachycardia or tremor. The series there- fore consisted of 200 patients where the clinical record and electrocardiogram were suitable for analysis.
    [Show full text]
  • Rheumatic Endocarditis
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1938 Rheumatic endocarditis Roy F. Pierson University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Pierson, Roy F., "Rheumatic endocarditis" (1938). MD Theses. 690. https://digitalcommons.unmc.edu/mdtheses/690 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. .RHEUKATIC ENDOCARDITIS Boy :r. Pieraon SENIOR THESIS PRESENTED TO - THE UNIVERSITY OF NEBR. COLLEGE OF llmDICINE Olt:AHA, 1938 INDEX· DEFINITION 1 I NT RODUCTI ON 2 HISTORY 3 INCIDENCE 15 ETIOLOGY 26 PATHOLOGY 36 SYMPTOMS AND DIAGNOSIS 59 TREATMENT 70 BIBLIOGRAPHY 80 480967 DEFINITION Bbeumatic Endocarditis is an inflammat­ ory disease of the endoeardium associated with :Rheumatic Fever. The disease process is charact­ erized by its indefinitely prolonged febrile course, a tendeney toward relapses, arthritic and nervous manifestations, •ubcutaneous nodules and changes in the endoeardium and myoeardium which are dependent upon the extensiveness of involvement. -l- .......... INTRODUCTION Rb.eumatie Endoearditia and its innocent counterpart, Hleuma.tic Fever have been associated since Piteairn first described this condition in 1788. Since that time they have been a most consp­ icuous thorn in the palm of the medical hand. For to this day, their origin has been concealed from the most discriminating minds of the profession.
    [Show full text]
  • Myocardial Injury and Pericarditis After Combined Left Atrial and Coronary
    Zheng et al. BMC Cardiovascular Disorders (2020) 20:18 https://doi.org/10.1186/s12872-020-01333-3 CASE REPORT Open Access Myocardial injury and pericarditis after combined left atrial and coronary sinus ablation in Wolff–Parkinson–White syndrome: a case report Mei-fang Zheng1,2†, Zhen Wang3,4† and Zheng-yu Bao1,3* Abstract Background: Radiofrequency catheter ablation is an established procedure with a high success rate for treating Wolff–Parkinson–White (WPW) syndrome. Rare complications post-ablation may nonetheless occur particularly associated with coronary sinus. Identifying and avoiding these complications remains a challenge. Case presentation: A 66-year-old woman with WPW syndrome was admitted to the hospital due to frequent attacks of paroxysmal tachycardia. During electrophysiological study, an accessory pathway was thought to connect the posterior wall of the left ventricle. The patient underwent Radiofrequency (RF) catheter ablation. The procedure was time-consuming because of combined left atrial and coronary sinus ablation. The total amount of radiofrequency application energy in the coronary sinus was 6800 J. After the operation, widespread concave ST- segment elevation, significantly increased value of serum troponin I and mild pericardial effusion were identified, but the patient did not show any symptoms. Therefore, the patient was suspected to have myocardial injury and pericarditis caused by ablation-related injury. The patient was uneventfully discharged five days after the procedure with a significantly decreased value of troponin I. The reexamined electrocardiogram was normal after three weeks. Conclusions: To the best of our knowledge, this is the first study to report on myocardial injury and pericarditis after combined left atrial and coronary sinus ablation in WPW syndrome.
    [Show full text]
  • Management of Asymptomatic Arrhythmias
    Europace (2019) 0, 1–32 EHRA POSITION PAPER doi:10.1093/europace/euz046 Downloaded from https://academic.oup.com/europace/advance-article-abstract/doi/10.1093/europace/euz046/5382236 by PPD Development LP user on 25 April 2019 Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS) David O. Arnar (Iceland, Chair)1*, Georges H. Mairesse (Belgium, Co-Chair)2, Giuseppe Boriani (Italy)3, Hugh Calkins (USA, HRS representative)4, Ashley Chin (South Africa, CASSA representative)5, Andrew Coats (United Kingdom, HFA representative)6, Jean-Claude Deharo (France)7, Jesper Hastrup Svendsen (Denmark)8,9, Hein Heidbu¨chel (Belgium)10, Rodrigo Isa (Chile, LAHRS representative)11, Jonathan M. Kalman (Australia, APHRS representative)12,13, Deirdre A. Lane (United Kingdom)14,15, Ruan Louw (South Africa, CASSA representative)16, Gregory Y. H. Lip (United Kingdom, Denmark)14,15, Philippe Maury (France)17, Tatjana Potpara (Serbia)18, Frederic Sacher (France)19, Prashanthan Sanders (Australia, APHRS representative)20, Niraj Varma (USA, HRS representative)21, and Laurent Fauchier (France)22 ESC Scientific Document Group: Kristina Haugaa23,24, Peter Schwartz25, Andrea Sarkozy26, Sanjay Sharma27, Erik Kongsga˚rd28, Anneli Svensson29, Radoslaw Lenarczyk30, Maurizio Volterrani31, Mintu Turakhia32,
    [Show full text]
  • A Closer Look: Documentation and Coding for Cardiac Conditions
    A Closer Look: Documentation and Coding for Cardiac Conditions Heart disease is a broad term used to describe a range of diseases that affect the heart. The various diseases that fall under the umbrella of heart disease include diseases of the heart and blood vessels. The term “heart disease" is often used interchangeably with "cardiovascular disease." Cardiovascular disease generally refers to conditions that involve narrowed or blocked blood vessels that can lead to a heart attack, angina or stroke. Other heart conditions, such as infections and conditions that affect the heart's muscle, valves or beating rhythm are also considered forms of heart disease. All types of heart disease share common traits, but they also have key differences. The goal of this article is to spend some time looking at documentation and diagnosis coding for conditions that fall under the cardiac conditions umbrella to achieve accurate and compliant practices. Dysrhythmias Cardiac dysrhythmia (also known as arrhythmia or irregular heartbeat) is any of a group of conditions in which the electrical activity of the heart is irregular or is faster or slower than normal. The following are some common types of arrhythmia. Tachycardia is an abnormally fast resting heart rate, usually exceeding 100 beats per minute. Supraventricular tachycardia (SVT) is a burst of rapid heartbeats occurring in the top portion of the ventricles. Paroxysmal means the arrhythmia begins and ends suddenly. If the documentation is unclear, the Physician may need to be queried for clarification. Ventricular tachycardia is an abnormal electrical impulse that originates in the ventricles. It may be documented as nonsustained (lasting for less than 30 seconds) or sustained.
    [Show full text]